A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues Yan Gu; Yao Zhang; Zhiyi Zhang; Jian Wang; Qing Zhang; Shaoqiu Zhang; Yilin Liu; Jiacheng Liu; Juan Xia; Xiaomin Yan; Jie Li; Xingxiang Liu; Rui Huang; Chao Wu;

48 weeks outcome after cessation of nucleos(t)ide analogue therapy in chronic hepatitis B patients Li Gao; Yue Hu; Xiaofeng Shi; Xin Li; Dazhi Zhang; Hong Ren;

cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B Patricia Gita Naully; Marselina Irasonia Tan; Agustiningsih Agustiningsih; Caecilia Sukowati; Ernawati Arifin Giri-Rachman;